sST2 is a key outcome biomarker in COVID-19: insights from discovery randomized trial
-
期刊论文
-
出版模式:
开放获取
-
发表日期:
2025年4月24日
- David M. Smadja,
- Clément R. Massonnaud,
- Aurélien Philippe,
- Mickael Rosa,
- Sophie Luneau,
- Antoine Rauch,
- Nathan Peiffer-Smadja,
- Amandine Gagneux-Brunon,
- Julien Poissy,
- Maxime Gruest,
- Alexandre Ung,
- Valérie Pourcher,
- François Raffi,
- Lionel Piroth,
- Kévin Bouiller,
- Hélène Esperou,
- Christelle Delmas,
- Drifa Belhadi,
- Alpha Diallo,
- Juliette Saillard,
- Aline Dechanet,
- Noémie Mercier,
- Axelle Dupont,
- François-Xavier Lescure,
- François Goehringer,
- Stéphane Jaureguiberry,
- François Danion,
- Violaine Tolsma,
- André Cabie,
- Johan Courjon,
- Sylvie Leroy,
- Joy Mootien,
- Bruno Mourvillier,
- Sébastien Gallien,
- Jean-Philippe Lanoix,
- Elisabeth Botelho-nevers,
- Florent Wallet,
- Jean-Christophe Richard,
- Jean Reuter,
- Alexandre Gaymard,
- Richard Greil,
- Guillaume Martin-Blondel,
- Claire Andrejak,
- Yazdan Yazdanpanah,
- Charles Burdet,
- Jean-Luc Diehl,
- Maya Hites,
- Florence Ader,
- Sophie Susen,
- France Mentré,
- Annabelle Dupont,
- Sandrine Couffin-Cadièrgues,
- Hélène Esperou,
- Bernd Lamprecht,
- Michael Joannidis,
- Alexander Egle,
- Richard Greil,
- Antoine Altdorfer,
- Vincent Fraipont,
- Leila Belkhir,
- Maya Hites,
- Gil Verschelden,
- Violaine Tolsma,
- David Bougon,
- Agathe Delbove,
- Marie Gousseff,
- Nadia Saidani,
- Guilhem Wattecamps,
- Félix Djossou,
- Loïc Epelboin,
- Jean-Philippe Lanoix,
- Pierre-Alexandre Roger,
- Claire Andrejak,
- Yoann Zerbib,
- Kevin Bouiller,
- Catherine Chirouze,
- Jean-Christophe Navellou,
- Alexandre Boyer,
- Charles Cazanave,
- Alexandre Duvignaud,
- Didier Gruson,
- Denis Malvy,
- Henry Lessire,
- Martin Martinot,
- Pascal Andreu,
- Mathieu Blot,
- Lionel Piroth,
- Jean Pierre Quenot,
- Olivier Epaulard,
- Nicolas Terzi,
- Karine Faure,
- Emmanuel Faure,
- Julien Poissy,
- Saad Nseir,
- Florence Ader,
- Laurent Argaud,
- Tristan Ferry,
- Thomas Perpoint,
- Vincent Piriou,
- Jean-Christophe Richard,
- Julien Textoris,
- Florent Valour,
- Florent Wallet,
- André Cabié,
- Jean-Marie Turmel,
- Cyrille Chabartier,
- Rostane Gaci,
- Céline Robert,
- Alain Makinson,
- Vincent Le Moing,
- Kada Klouche,
- Olivier Hinschberger,
- Joy Mootien,
- Sébastien Gibot,
- François Goehringer,
- Antoine Kimmoun,
- Benjamin Lefevre,
- David Boutoille,
- Emmanuel Canet,
- Benjamin Gaborit,
- Paul Le Turnier,
- François Raffi,
- Jean Reignier,
- Johan Courjon,
- Jean Dellamonica,
- Sylvie Leroy,
- Charles-Hugo Marquette,
- Paul Loubet,
- Claire Roger,
- Albert Sotto,
- Cédric Bruel,
- Benoît Pilmis,
- Guillaume Geri,
- Elisabeth Rouveix-Nordon,
- Olivier Bouchaud,
- Samy Figueiredo,
- Stéphane Jaureguiberry,
- Xavier Monnet,
- Lila Bouadma,
- François-Xavier Lescure,
- Nathan Peiffer-Smadja,
- Jean-François Timsit,
- Yazdan Yazdanpanah,
- Solen Kerneis,
- Marie Lachâtre,
- Odile Launay,
- Jean-Paul Mira,
- Julien Mayaux,
- Valérie Pourcher,
- Jérôme Aboab,
- Flora Crockett,
- Naomi Sayre,
- Clément Dubost,
- Cécile Ficko,
- David Lebeaux,
- Sébastien Gallien,
- Armand Mekontso-Dessap,
- Jérôme Le Pavec,
- Francois Stefan,
- Hafid Ait-Oufella,
- Karine Lacombe,
- Jean-Michel Molina,
- Murielle Fartoukh,
- Gilles Pialoux,
- Firouzé Bani-Sadr,
- Bruno Mourvillier,
- François Benezit,
- Fabrice Laine,
- Bruno Laviolle,
- Yves Le Tulzo,
- Matthieu Revest,
- Elisabeth Botelho-Nevers,
- Amandine Gagneux-Brunon,
- Guillaume Thiery,
- François Danion,
- Yves Hansmann,
- Ferhat Meziani,
- Walid Oulehri,
- Charles Tacquard,
- Fanny Bounes-Vardon,
- Guillaume Martin-Blondel,
- Marlène Murris-Espin,
- Béatrice Riu-Poulenc,
- Vanessa Jeanmichel,
- Eric Senneville,
- Louis Bernard,
- Denis Garot,
- Jean Reuter,
- Thérèse Staub,
- Marc Berna,
- Sandra Braz,
- Joao Miguel Ferreira Ribeiro,
- José-Artur Paiva,
- Roberto Roncon-Albuquerque,
- Benjamin Leveau
摘要
We investigated whether baseline levels of biomarkers related to endotheliopathy, thromboinflammation, and fibrosis were associated with clinical outcomes in hospitalized COVID-19 patients. We analyzed the associations between baseline levels of 21 biomarkers and time to hospital discharge and change in NEWS-2 score in patients from DisCoVeRy trial. We fitted multivariate models adjusted for baseline ISARIC 4C score, disease severity, D-dimer values, and treatment regimen. Between March 22 and June 29, 2020, 603 participants were randomized; 454 had a sample collected at baseline and analyzed. The backward selection of multivariate models showed that higher baseline levels of soluble suppressor of tumorigenicity 2 (sST2) and nucleosomes were statistically associated with a lower chance of hospital discharge before day 29 (sST2: aHR 0.24, 95% CI [0.15–0.38], p < 10−9; nucleosomes: aHR 0.62, 95% CI [0.48–0.81], p < 10−3). Likewise, higher levels of baseline sST2 were statistically associated with lower changes in the NEWS-2 score between baseline and day 15 (adjusted beta 4.47, 95% CI [2.65–6.28], p < 10−5). Moreover, we evaluated sST2 involvement in a confirmation cohort (SARCODO study, 103 patients) and found that elevated baseline sST2 levels were significantly associated with lower rates of hospital discharge before day 29 and a higher model performance (AUC at day 29 of 92%) compared to models without sST2. sST2 emerged as an independent predictor of clinical outcomes in two large cohort of hospitalized COVID-19 patients, warranting further investigation to elucidate its role in disease progression and potential as a therapeutic target.